Literature DB >> 16127088

Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia.

Gokhan Metan, Omrum Uzun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16127088      PMCID： PMC1195400          DOI： 10.1128/AAC.49.9.3980-3981.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.

Authors:  Chung-Hsu Lai; Chih-Yu Chi; Hsin-Pai Chen; Te-Li Chen; Chorng-Jang Lai; Chang-Phone Fung; Kwok-Woon Yu; Wing-Wai Wong; Cheng-Yi Liu
Journal:  J Microbiol Immunol Infect       Date:  2004-12       Impact factor: 4.399

2.  Attributable mortality of Stenotrophomonas maltophilia bacteremia.

Authors:  Esin Senol; Jeffrey DesJardin; Paul C Stark; Laurie Barefoot; David R Snydman
Journal:  Clin Infect Dis       Date:  2002-05-24       Impact factor: 9.079

3.  Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.

Authors:  Cheol-In Kang; Sung-Han Kim; Wan Beom Park; Ki-Deok Lee; Hong-Bin Kim; Eui-Chong Kim; Myoung-Don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.

Authors:  A Micozzi; M Venditti; M Monaco; A Friedrich; F Taglietti; S Santilli; P Martino
Journal:  Clin Infect Dis       Date:  2000-10-04       Impact factor: 9.079
  4 in total
  15 in total

1.  Treatment of Stenotrophomonas neonatal urinary tract infection with instillation of ciprofloxacin.

Authors:  Mohammad Khassawneh; Wail Hayajneh
Journal:  Pediatr Nephrol       Date:  2010-02-18       Impact factor: 3.714

2.  Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients.

Authors:  Hayati Demiraslan; Mustafa Sevim; Çiğdem Pala; Süleyman Durmaz; Veli Berk; Leylagül Kaynar; Gökhan Metan
Journal:  Int J Hematol       Date:  2013-02-22       Impact factor: 2.490

3.  Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals.

Authors:  Sadia H Sarzynski; Sarah Warner; Junfeng Sun; Roland Matsouaka; John P Dekker; Ahmed Babiker; Willy Li; Yi Ling Lai; Robert L Danner; Vance G Fowler; Sameer S Kadri
Journal:  Open Forum Infect Dis       Date:  2022-01-17       Impact factor: 3.835

Review 4.  Clinical challenges treating Stenotrophomonas maltophilia infections: an update.

Authors:  Maria F Mojica; Romney Humphries; John J Lipuma; Amy J Mathers; Gauri G Rao; Samuel A Shelburne; Derrick E Fouts; David Van Duin; Robert A Bonomo
Journal:  JAC Antimicrob Resist       Date:  2022-05-05

5.  Cluster of Stenotrophomonas maltophilia endocarditis after prosthetic valve replacement.

Authors:  Manica Müller-Premru; Tone Gabrijelcic; Borut Gersak; Jana Kolman; Natasa Svent-Kucina; Vesna Spik; Tatjana Lejko-Zupanc
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

6.  Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia.

Authors:  J I Garcia Paez; F M Tengan; A A Barone; A S Levin; S F Costa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-16       Impact factor: 3.267

7.  Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.

Authors:  Yu Lin Wang; Marco R Scipione; Yanina Dubrovskaya; John Papadopoulos
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

8.  Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials.

Authors:  Lutz E Lehmann; Bernd Herpichboehm; Gerald J Kost; Marin H Kollef; Frank Stüber
Journal:  Crit Care       Date:  2010-10-15       Impact factor: 9.097

9.  Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study.

Authors:  Kosuke Sumida; Yong Chong; Noriko Miyake; Tomohiko Akahoshi; Mitsuhiro Yasuda; Nobuyuki Shimono; Shinji Shimoda; Yoshihiko Maehara; Koichi Akashi
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 10.  Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.

Authors:  Khalid Ahmed Al-Anazi; Asma M Al-Jasser
Journal:  Front Oncol       Date:  2014-08-25       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.